Search clinical trials for: RF-CWC

Total 1782 results

Per Løgstrup Poulsen
Odense University Hospital

Recruiting

Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetes (STENO INTEN-CT)

Cardiovascular Diseases | Type 2 Diabetes

Denmark
Chase Therapeutics Corporation

Active, not recruiting

A Study to Evaluate in Patients With Parkinsonian Type Disorders

Idiopathic Parkinson Disease

United States
Sohag University

Enrolling by invitation

Predictors of Acute Kidney Injury in Patients With Acute Decompensated Heart Failure in Emergency

Acute Kidney Injury | Acute Heart Failure

Egypt
Causeway Therapeutics

Completed

Safety, Tolerability, and Pharmacokinetics of Single Dose TenoMiR as a Treatment for Tennis Elbow

Tennis Elbow

United Kingdom
Rosimeire Simprini Padula

Completed

Resistance Exercise to Improve Fatigue in Workplace (REW) (REW)

Fatigue | Musculoskeletal Diseases

Brazil
London North West Healthcare NHS Trust

Completed

Detection in Tandem Endocuff Cap Trial (DETECT)

Colonic Neoplasms | Colo-rectal Cancer | Colon Adenoma | Adenomas Serrated

United Kingdom
University Hospital, Basel, Switzerland

Completed

Septic Encephalopathy and Late Cognitive Dysfunction

Sepsis | Severe Sepsis

Switzerland
University of Virginia
DexCom, Inc.; Insulet Corporation; Abbott Diabetes Care; University of California...

Completed

Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Mellitus (MDB003)

Type 1 Diabetes Mellitus

United States
Tel-Aviv Sourasky Medical Center
Amorphical Ltd.

Unknown

Amorphous Calcium Carbonate (Acc) Versus Crystalline Calcium Carbonate (Ccc) Using Stable Calcium Isotopes In Postmenopausal Women

Postmenopause

Israel
EarliTec Diagnostics, Inc
Marcus Autism Center

Completed

Dynamic Quantification of Social-Visual Engagement in Autism Spectrum Disorder (ASD) (MEASURE-ASD2)

Autism Spectrum Disorder | Autism

United States
University of Alberta

Withdrawn

Does Higher (100% Oxygen) Versus Lower (21% Oxygen) During CC+SI During CPR of Asphyxiated Newborns Improve Time to ROSC (SURV1VE-O2)

Bradycardia Neonatal | Birth Asphyxia | Heart; Arrest, Newborn

Canada
Mansoura University

Completed

Flowable Resin Composite: Two-Year Clinical Performance in Class I Restorations

Class I Dental Caries

Egypt
DePaul University
National Institute of Mental Health (NIMH)

Active, not recruiting

Preventing Suicide in African American Adolescents

Suicide

United States
Joseph Tuscano
National Cancer Institute (NCI); Celgene

Completed

CC-486, Lenalidomide, and Obinutuzumab for the Treatment of Recurrent or Refractory CD20 Positive B-cell Lymphoma

Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Hairy Cell Leukemia | Refractory Mantle Cell Lymphoma | Recurrent... and other conditions

United States
Novartis Pharmaceuticals
Allergan

Completed

Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis (TANDEM)

Non-alcoholic Steatohepatitis (NASH)

United States, Belgium, Spain, Canada, Argentina, Israel, Germany, France, Italy, Turkey, Singapore, Russian Federation, United Kingdom, Czechia, Egypt, India, Latvia
Mayo Clinic
National Cancer Institute (NCI)

Terminated

Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis

Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Monoclonal B-Cell Lymphocytosis | Stage I Small Lymphocytic Lymphoma

United States
Kaiser Clinic and Hospital

Completed

Optimization and Follow-up of the Consecutive Use of Two Intragastric Balloons in the Treatment of Obesity

Obesity | Metabolic Syndrome

Brazil
VA Office of Research and Development

Terminated

Home-based Conservative Care Model for Advanced Kidney Disease

Chronic Kidney Diseases

United States
Celgene

Terminated

A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes

Myelodysplastic Syndromes | Leukemia, Myeloid, Acute

United States, France, Canada, Norway, Spain, United Kingdom
Celgene

Terminated

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin's Lymphomas

Neoplasms | Lymphoma, Non-Hodgkin

France, Italy, Japan, Spain
Celgene

Terminated

A Study of CC-122 to Assess the Safety and Tolerability in Japanese Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma (NHL)

Lymphoma, Non-Hodgkin

Japan
Nobel Biocare

Completed

A 5-year Clinical Evaluation Study on NobelReplace Conical Connection Implants

Healthy | Implant
Celgene

Completed

A Study to Assess the Pharmacokinetics of CC-90001 in Subjects With Mild, Moderate, and Severe Hepatic Impairment Compared With Healthy Subjects

Hepatic Impairment

United States
Celgene

Completed

Radiolabeled Study of CC-122 in Healthy Subjects

Healthy Volunteers

United States
Universitair Ziekenhuis Brussel

Unknown

Multicenter Prospective Cumulus Cell Test Study (MC_CC-Test)

Pregnancy

Belgium
Celgene

Completed

A Study to Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderate, and Severe Renal Impairment

Renal Insufficiency

United States
Celgene

Completed

A Study to Assess the Relative Bioavailability of a New CC-220 Capsule Formulation, Compared to a Reference CC-220 Capsule Formulation, in Healthy Adult Subjects

Healthy Volunteers

United States
Celgene Corporation

Completed

Effect of UV Exposure on the PD of Multiple Doses of CC-90001 and Pilot Food Effect Study

Healthy Subjects

United States
Celgene Corporation

Terminated

Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia

Myeloid Leukemia

United States
Philip Morris Products S.A.

Completed

Evaluation of Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2 for 26 Weeks

Smoking

United States
Memorial Sloan Kettering Cancer Center
Celgene Corporation

Completed

Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer

Prostate Cancer | Castration Resistant Prostate Cancer

United States
Celgene

Completed

A Study to Evaluate the Metabolism and Excretion of [14C]-CC-90009 in Healthy Male Subjects

Healthy Volunteer

United States
Celgene

Completed

Metabolism and Excretion of [14C]CC-90001 in Healthy Male Subjects

Healthy Volunteer

United States
Philip Morris Products S.A.

Completed

A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2

Smoking

United States
Celgene

Completed

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CC-90006 in Healthy Subjects

Healthy Volunteers

United States
Celgene Corporation

Completed

3-part Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Multiple Doses of CC-220 and Relative Bioavailability of a Formulated CC-220 Capsule

Healthy Volunteers

United States
Celgene

Completed

Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS).

Myelodysplastic Syndromes | Leukemia, Myeloid, Acute

United States, United Kingdom
Assiut University

Not yet recruiting

Outcome of Cardiomyopathic Adults Admission in ICU.

Cardiomyopathies
Sino Medical Sciences Technology Inc.
Peking University First Hospital

Completed

Compare the Effectiveness and Safety of Two Different Kinds of Cutting Balloon in Coronary Artery Disease

Coronary Stenosis | Coronary Artery Stenosis | In-stent Restenosis

China
Minia University

Completed

Fundus-first Laparoscopic Cholecystectomy (FFLC)

Cholecystitis | Acute Cholecystitis | Pericholecystic Abscess

Egypt
Chase Therapeutics Corporation

Active, not recruiting

A Study in Patients With Major Depressive Disorder

Major Depressive Disorder (MDD)

United States
Beckman Coulter, Inc.

Completed

Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Washington University

Sepsis | Severe Sepsis | Emergency Department | Adult Disease

United States
ReShape Lifesciences

Active, not recruiting

The ReNEW Study: Maestro® New Enrollment Post-Approval Study Protocol (ReNEW)

Obesity, Morbid

United States
Lincoln University College
Cairo University; Taif University

Not yet recruiting

Effect of Knee Extensor Training on the Lumbar Spine

Non Specific Low Back Pain
University of Florida

Completed

Effects of Carboxymethylcellulose Artificial Tears on the Eye Microbiome

Dry Eye Syndromes

United States
BIONCaRT GmbH
KKS Netzwerk; Polski Bank Komorek Macierzystych JSC (PBKM); Fraunhofer Institute...

Recruiting

Safety and Efficacy of hUC-MSC for the Treatment of Cartilage Damage in the Knee Joint (BPCC001)

Cartilage Damage

Germany
Celgene

Completed

A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus

Lupus Erythematosus, Systemic

United States, Belgium, Germany, Spain, Canada, Serbia, Colombia, Poland, Argentina, Brazil, Mexico, Hungary, France, Russian Federation, Italy
Celgene

Completed

A Study to Assess Safety, Tolerability, and Pharmacokinetics of CC-92480 Formulations in Healthy Adult Participants

Healthy Volunteers

United States
Celgene

Terminated

A Safety Study of CC-92252 in Healthy Adult Subjects and Adult Subjects With Psoriasis

Psoriasis | Healthy Volunteers

Germany
Celgene

No longer available

Expanded Access for Marizomib

Solid Tumor

United States

Search clinical trials for: RF-CWC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations